首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Recombinant human erythropoietin attenuates weight loss in a murine cancer cachexia model
【24h】

Recombinant human erythropoietin attenuates weight loss in a murine cancer cachexia model

机译:重组人类促红细胞生成素减轻鼠癌症恶病质模型的体重减轻

获取原文
获取原文并翻译 | 示例
       

摘要

Within hypoxic tumor regions anaerobic dissimilation of glucose is the sole source of energy generation. It yields only 5% of the ATP that is normally gained by means of oxidative glucose catabolism. The increased need for glucose may aggravate cancer cachexia. We investigated the impact of recombinant human erythropoietin (RhEPO) and increased inspiratory oxygen concentrations on weight loss in tumor-bearing mice.
机译:在缺氧的肿瘤区域内,葡萄糖的厌氧消化是产生能量的唯一来源。它仅产生通常通过氧化葡萄糖分解代谢获得的ATP的5%。对葡萄糖的需求增加可能加剧癌症恶病质。我们调查了重组人促红细胞生成素(RhEPO)和增加的吸氧浓度对荷瘤小鼠体重减轻的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号